Design, synthesis, and bioevaluation of imidazo [1,2–a] pyrazine derivatives as tubulin polymerization inhibitors with potent anticancer activities
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Design, synthesis, and bioevaluation of imidazo [1,2–a] pyrazine derivatives as tubulin polymerization inhibitors with potent anticancer activities
Authors
Keywords
-
Journal
BIOORGANIC & MEDICINAL CHEMISTRY
Volume 76, Issue -, Pages 117098
Publisher
Elsevier BV
Online
2022-11-20
DOI
10.1016/j.bmc.2022.117098
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Discovery of novel coumarin-indole derivatives as tubulin polymerization inhibitors with potent anti-gastric cancer activities
- (2022) Jian Song et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of (2-(pyrrolidin-1-yl)thieno[3,2-d]pyrimidin-4-yl)(3,4,5-trimethoxyphenyl)methanone as a novel potent tubulin depolymerizing and vascular disrupting agent
- (2022) Chao Tian et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Corrigendum to “Re-expression of LKB1 in LKB1-mutant EKVX cells leads to resistance to paclitaxel through the up-regulation of MDR1 expression” [Lung Cancer 88/2 (2015) 131–138]
- (2021) Kaisheng Mao et al. LUNG CANCER
- Discovery of Novel Benzimidazole and Indazole Analogues as Tubulin Polymerization Inhibitors with Potent Anticancer Activities
- (2021) Yichang Ren et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design, synthesis and evaluation of novel bis-substituted aromatic amide dithiocarbamate derivatives as colchicine site tubulin polymerization inhibitors with potent anticancer activities
- (2021) Ya-Xin Sun et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis of N‐Carbonyl Acridanes as Highly Potent Inhibitors of Tubulin Polymerization via One‐Pot Copper‐Catalyzed Dual Arylation of Nitriles with Cyclic Diphenyl Iodoniums
- (2020) Xiaopeng Peng et al. ADVANCED SYNTHESIS & CATALYSIS
- Tubulin Maytansine Site Binding Ligands and Their Applications as MTAs and ADCs for Cancer Therapy
- (2020) Shuo Cao et al. CURRENT MEDICINAL CHEMISTRY
- Design, synthesis, in vitro and in vivo biological evaluation of 2-amino-3-aroylbenzo[b]furan derivatives as highly potent tubulin polymerization inhibitors
- (2020) Paola Oliva et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design, synthesis, and bioevaluation of pyrazolo[1,5-a]pyrimidine derivatives as tubulin polymerization inhibitors targeting the colchicine binding site with potent anticancer activities
- (2020) Gang Li et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Pyrrolo[2′,3′:3,4]cyclohepta[1,2-d][1,2]oxazoles, a New Class of Antimitotic Agents Active against Multiple Malignant Cell Types
- (2020) Virginia Spanò et al. JOURNAL OF MEDICINAL CHEMISTRY
- A stereotetrad-centered approach toward pironetin: Dead ends, Detour, and evolution of the synthetic strategy
- (2020) Qi Gu et al. TETRAHEDRON
- Cyclic bridged analogs of isoCA-4: Design, synthesis and biological evaluation
- (2020) Shannon Pecnard et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- [Corrigendum] Downregulation of nucleolar and spindle‑associated protein 1 expression suppresses cell migration, proliferation and invasion in renal cell carcinoma
- (2020) Lu Fang et al. ONCOLOGY REPORTS
- Tubulin colchicine site binding agent LL01 displays potent antitumor efficiency both in vitro and in vivo with suitable drug-like properties
- (2019) Jing-De Wu et al. INVESTIGATIONAL NEW DRUGS
- Synthesis and bioevaluation of diarylpyrazoles as antiproliferative agents
- (2019) Chao Wang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Structure-Guided Design, Synthesis, and Biological Evaluation of (2-(1H-Indol-3-yl)-1H-imidazol-4-yl)(3,4,5-trimethoxyphenyl) Methanone (ABI-231) Analogues Targeting the Colchicine Binding Site in Tubulin
- (2019) Qinghui Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design, synthesis, and biological evaluation of 1-substituted -2-aryl imidazoles targeting tubulin polymerization as potential anticancer agents
- (2019) Ling Li et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design and synthesis of substituted dihydropyrimidinone derivatives as cytotoxic and tubulin polymerization inhibitors
- (2019) Sravani Sana et al. BIOORGANIC CHEMISTRY
- Heterocyclic-Fused Pyrimidines as Novel Tubulin Polymerization Inhibitors Targeting the Colchicine Binding Site: Structural Basis and Antitumor Efficacy
- (2018) Souvik Banerjee et al. JOURNAL OF MEDICINAL CHEMISTRY
- 3,5-Diaryl-1H-pyrazolo[3,4-b]pyridines as potent tubulin polymerization inhibitors: Rational design, synthesis and biological evaluation
- (2018) Min'an Zhai et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design, synthesis and anticancer properties of Iso CombretaQuinolines as potent tubulin assembly inhibitors
- (2017) Ilhem Khelifi et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Tubulin inhibitors targeting the colchicine binding site: a perspective of privileged structures
- (2017) Wenlong Li et al. Future Medicinal Chemistry
- The development and use of vascular targeted therapy in ovarian cancer
- (2017) Dana M. Chase et al. GYNECOLOGIC ONCOLOGY
- Taxol®: The First Microtubule Stabilizing Agent
- (2017) Chia-Ping Yang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Structural Basis of cis - and trans -Combretastatin Binding to Tubulin
- (2017) Roberto Gaspari et al. Chem
- IsoCombretaQuinazolines: Potent Cytotoxic Agents with Antitubulin Activity
- (2015) Mohamed Ali Soussi et al. ChemMedChem
- Microtubule-targeting agents are clinically successful due to both mitotic and interphase impairment of microtubule function
- (2014) Jessica J. Field et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Recent advances in vascular disrupting agents in cancer therapy
- (2014) Elena Porcù et al. Future Medicinal Chemistry
- Design, Synthesis, and Biological Evaluation of Stable Colchicine Binding Site Tubulin Inhibitors as Potential Anticancer Agents
- (2014) Yan Lu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Targeting Microtubules by Natural Agents for Cancer Therapy
- (2014) E. Mukhtar et al. MOLECULAR CANCER THERAPEUTICS
- Quercetin Inhibits Proliferation and Drug Resistance in KB/VCR Oral Cancer Cells and Enhances Its Sensitivity to Vincristine
- (2014) Zhaohu Yuan et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Clinical features of taxane neuropathy
- (2013) David Kudlowitz et al. ANTI-CANCER DRUGS
- Tubulin inhibitors: a patent review
- (2013) Yi-Min Liu et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Genome-wide association study identifies ephrin type A receptors implicated in paclitaxel induced peripheral sensory neuropathy
- (2013) Luis J Leandro-García et al. JOURNAL OF MEDICAL GENETICS
- Tubulin-based Structure-affinity Relationships for Antimitotic Vinca Alkaloids
- (2012) Claire Coderch et al. Anti-Cancer Agents in Medicinal Chemistry
- Discovery of Novel 2-Aryl-4-benzoyl-imidazole (ABI-III) Analogues Targeting Tubulin Polymerization As Antiproliferative Agents
- (2012) Jianjun Chen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis and antiproliferative activity of novel 2-aryl-4-benzoyl-imidazole derivatives targeting tubulin polymerization
- (2011) Jianjun Chen et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Design, Synthesis, and SAR Studies of 4-Substituted Methoxylbenzoyl-aryl-thiazoles Analogues as Potent and Orally Bioavailable Anticancer Agents
- (2011) Yan Lu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Novel 2-Aryl-4-benzoyl-imidazoles Targeting the Colchicines Binding Site in Tubulin As Potential Anticancer Agents
- (2010) Jianjun Chen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of 4-Substituted Methoxybenzoyl-aryl-thiazole as Novel Anticancer Agents: Synthesis, Biological Evaluation, and Structure−Activity Relationships
- (2009) Yan Lu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Isocombretastatins A versus Combretastatins A: The ForgottenisoCA-4 Isomer as a Highly Promising Cytotoxic and Antitubulin Agent
- (2009) Samir Messaoudi et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery ofN-(4-Methoxyphenyl)-N,2-dimethylquinazolin-4-amine, a Potent Apoptosis Inducer and Efficacious Anticancer Agent with High Blood Brain Barrier Penetration
- (2009) Nilantha Sirisoma et al. JOURNAL OF MEDICINAL CHEMISTRY
- Cell-cycle control in the face of damage – a matter of life or death
- (2009) Paul R. Clarke et al. TRENDS IN CELL BIOLOGY
- Inhibition of the Ras-Net (Elk-3) Pathway by a Novel Pyrazole that Affects Microtubules
- (2008) C. Wasylyk et al. CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started